Protamine sulfate enhances lipid-mediated gene transfer

Area of Science:

• Biochemistry
• Molecular Biology
• Gene Therapy

Background:

• Gene delivery relies on efficient DNA condensation for cellular uptake.
• Polycationic peptides are explored as agents for DNA condensation.
• Protamine sulfate is an FDA-approved compound with potential in gene therapy.

Purpose of the Study:

• To evaluate protamine sulfate as a DNA condensation agent for gene delivery.
• To compare protamine sulfate's efficacy with other condensation agents like poly-L-lysine.
• To investigate the structural basis for protamine sulfate's DNA condensation and transfection-enhancing activity.

Main Methods:

• In vitro transfection assays using various cationic liposomes and cell types.
• Comparison of protamine sulfate with poly-L-lysine and other protamine variants.
• Analysis of protamine structure and its correlation with DNA binding and transfection.

Main Results:

• Protamine sulfate efficiently condenses plasmid DNA, enhancing transfection comparable to lipofectamine.
• Protamine sulfate demonstrated superior condensation and transfection activity compared to poly-L-lysine.
• Structural differences in protamine, particularly lysine residue content, influenced DNA binding and transfection efficacy.

Conclusions:

• Protamine sulfate is a superior DNA condensation agent for gene delivery.
• The structural features of protamine, not solely net charge, are critical for its function.
• Protamine sulfate's established safety profile makes it a promising adjuvant for human gene therapy protocols.